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Delays in the labbratory examination of cerebrospinal fluid are commonly encountered in clinical medicine.
The present studies were designed to evaluate changes in cerebrospinal fluid leukocyte counts relative to time
elapsed before analysis; Neutrophil counts decreased most rapidly, being 68 10% (standard error of the
mean) and 50 12% of initial values at 1 and 2 h, respectively. Lymphocyte and monocyte numbers were not
significantly altered until 3 h.
Under ideal clinical circumstances, cerebrospinal fluid
(CSF) obtained by lumbar puncture is rapidly transported to
the pathology laboratory for analysis. Management deci-
sions can then be made based on reported CSF parameters.
There are, however, many circumstances which may delay
analysis of spinal fluid, particularly if the patient is trans-
ferred to a referral center following a lumbar puncture which
yielded cloudy CSF. It is also not unusual for specimens to
remain in an emergency room for an hour or more while the
patient is stabilized and treatment instituted, because these
are priority concerns. Delays also occur in the clinical
laboratory where technicians may first complete other ongo-
ing tests.
Because CSF is hypotonic (2) (specific gravity, 1.007),
leukocytes lyse if left in this medium for extended periods.
For most cases of bacterial meningitis, such, a delay should
hot confuse interpretation of laboratory data. However,
there are some situations, such as the differentiation of early
bacterial meningitis from aseptic meningitis, in which cell
counts may be more critical. We therefore analyzed survival
of neutrophils, lymphocytes, and monocytes in CSF over
-periods comparable to, the duration of delay in processing
often encountered in clinical practice.
Lymphocytes and monocytes were separated from periph-
eral whole blood by using a Ficoll-Hypaque density gradient,
and neutrophils were obtained by double-density gradient
centrifugation as previously described (7). With this mneth-
odology, cell populations (mononuclear or neutrophil) were
>90% pure. Acridine orange was used to differentiate cell
types in the counting procedures.
CSF was pooled from samples sent to the clinical labora-
tory during the evaluation of possible meningitis in children.
These samples had normal parameters, including fewer than
10 mononuclear cells per mm3. All fluids were centrifuged to
remove cells and passed through Millipore membrane filters
to eliminate other possible contaminants.
Sterile plastic tubes were used for all studies, because they
are equivalent to containers normally used to collect CSF. In
early experiments, cells were shown not to adhere to plastic,
because the addition of trypsin did not increase the recovery
of leukocytes. Purified leukocyte populations were adjusted
to various concentrations from 0.4 x 106 to 1.25 x 106/ml
* Corresponding author.
(400 to 1,250/mm3) in CSF and placed at room temperature
before reanalysis of cell counts. These experiments were
repeated at least 11 times with different donors. Controls
included similar cell populations maintained for the same
time in buffered normal saline.
CSF neutrophils. To assure that the experimental condi-
tions of this study accurately reflected the status of leuko-
cytes in infected CSF, fresh spinal fluid was obtained from
five patients undergoing therapy for culture-positive bacte-
rial meningitis. All had a pleocytosis greater than 1,000/mm3
at the time of sampling. The CSF leukocytes were examined
for viability and functional capacity as described below.
Viability and functional capacity of neutrophils. An assay
using acridine orange as a vital stain was used to assess the
viability of neutrophils and, at the same time, to directly
visualize phagocytic and killing processes of peripheral
blood or CSF cells. Live bacteria stain green with acridine
orange, and this color changes to bright red when the
bacteria are killed by phagocytes. Details of this assay were
previously reported (9). Briefly, monolayers were first pre-
pared by placing 5 drops of purified peripheral leukocytes or
5 drops of CSF obtained from meningitis patients onto flat
glass cover slips and allowing attachment of these cells
during 1 h of incubation at 37°C in 5% Co2. The supernatant
fluid was then removed by gentle washing with normal
saline, and 2 drops of preopsonized Streptococcus pneumo-
niae type 14 containing approximately 108 bacteria per ml in
phenol-free Hanks balanced salt solution with 10% autolo-
gous human serum were placed on the cell monolayers.
Cover slips were then incubated at 37°C for 90 min. After
incubation, monolayers were washed twice with normal
saline and stained for 1 min with 0.14% acridine orange in
Gey balanced salt solution. Cover slips were mounted face
down and examined by fluorescence microscopy. Approxi-
mately 100 neutrophils were counted, and the total humber
of bacteria phagocytized and the percent killed (red) and
percent alive (green) were recorded. Viability of cells at all
time points was >90%; therefore, enumerated cells were
considered viable for data presentation.
No differences in leukocyte survival were seen according
to the beginning cell count or to the leukocyte donor.
Therefore, all data were combined for analysis. Changes in
cell counts by time are shown in Table 1. To simplify
interpretation, data are presented as percentage of the initial
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TABLE 1. Survival of leukocytes in CSF
% of Cell count at 0 h ± SEM at the following time (h):
Cell population
0.5 1 2 3 4
Neutrophils 91 ± 2 68 + 10 50 ±12 48 ± 10 42 ± 11
Lymphocytes 94 ± 7 91 ±8 88 ± 10 69 ± 7 66 ± 5
Monocytes 98 ± 10 90 ± 7 80 ± 8 66 ± 7 61 ± 8
(zero time) leukocyte concentration. A more rapid decrease
in the neutrophil population compared with mononuclear
cells was evident, with only half of the neutrophils remaining
by 2 h. Lymphocyte survival was similar to that in monocyte
studies in that significant reductions (P < 0.05, compared
with zero time) were not seen until 3 h in CSF.
Lymphocytes and monocytes maintained in buffered nor-
mal saline for 4 h at room temperature never demonstrated
any change in concentration; in contrast, neutrophil concen-
trations decreased to 87 + 2% (standard error of the mean)
and 82 ± 5% at 3 and 4 h, respectively (both P < 0.05,
compared with initial counts). At all time points, 0.5 to 4 h,
neutrophils in CSF had significantly reduced concentrations
compared with those in buffered saline (P < 0.01).
Viability of peripheral blood neutrophils 1 h after being
added to CSF was 95.6 ± 2.4% compared with that of
neutrophils recovered from patients with meningitis, which
were 94.1 ± 5.3% viable (P > 0.05). The average numbers of
bacteria phagocytized (4.7 ± 0.7 versus 5.1 ± 1.6) and
percent killed (75.8 ± 11.5% versus 71.7 ± 7.2%) were not
significantly different for the two neutrophil sources.
It is important in the practice of medicine to recognize
those occasions in which a delay in the laboratory testing of
specimnens may alter results. Cell counts in CSF represent
such a circumstance. Relevant clinical situations might best
suggest times when the recalculation of counts following
delay in CSF analysis might be considered. A minimal
pleocytosis of 10 to 30 cells per mm3 may be seen with
tuberculous and fungal meningitis (3), central nervous sys-
tem syphilis (5), and herpes encephalitis (8). This is not much
different from the normal CSF counts in children of .10
mononuclear cells per mm3 and adults of c5 cells per mm3.
As a contrasting feature in the differentiation of Guillain-
Barre syndrome from poliomyelitis or aspetic meningitis, a
cell count less than 50/mm3 is more compatible with the
former, whereas a greater pleocytosis is more characteristic
of the latter (1). Accurate cell counts are important in the
management of partially treated meningitis, because ade-
quacy of therapy is in part determined by this parameter in
repeat lumbar punctures (4).
Analysis of CSF leukocytes from patients with meningitis
for viability and functional capacity, i.e., phagocytosis and
microbial killing, indicated that the present mixing experi-
ments were comparable to the in vivo situation. These
studies of recovered CSF neutrophils therefore support
further interpretation of our in vitro data.
The decrease in neutrophil count at 1 h by 32% and at 2 h
by 50% of the initial concentration suggests that clinical
errors may occur if analysis of samples is delayed. It is not
surprising that neutrophils lysed more rapidly than lympho-
cytes or monocytes, because under ideal circumstances
neutrophils remain viable for only 7 h. Besides hypotonicity
of CSF, low concentrations of proteins and lipids which
normally function to stabilize leukocyte membranes would
also contribute to cell destruction (6). Our buffered normal
saline controls, which were isotonic but contained no plasma
proteins and lipids, demonstrated that lack of membrane
stabilization accounts for some neutrophil destruction, but
only after 3 h.
These data emphasize the need for clinicians to assure the
rapid analysis of CSF. If this cannot be achieved, correc-
tions may be used for cell counts based on the du'ration of
delay in examination.
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